300627-48-9

Basic information

• Product Name: Benzonitrile, 4-amino-2-iodo-
• CAS NO: 300627-48-9
• Molecular Formula: C7H5IN2
• Molecular Weight: 244.035
• Mol File: 300627-48-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 4-amino-2-iodo-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 4-amino-2-iodo-(300627-48-9)
• EPA Substance Registry System: Benzonitrile, 4-amino-2-iodo-(300627-48-9)

Safety Data

• Hazardous Substances Data: 300627-48-9(Hazardous Substances Data)

Upstream product

• 619-17-0 4-Nitroanthranilic acid 
• 7439-89-6 iron 
• 300627-43-4 2-iodo-4-nitrobenzonitrile 
• 861602-59-7 2-iodo-4-nitrobenzoyl chloride 
• 89459-38-1 4-nitro-2-iodobenzoic acid 
• 89677-75-8 2-iodo-4-nitrobenzamide 
• 6293-83-0 2-iodo-4-nitrophenylamine 

Downstream Products

• 300627-53-6 2-iodo-4-isothiocyanatobenzonitrile 
• 793668-24-3 2-iodo-4-isocyanato-benzonitrile 
• 824936-26-7 (2R)-N-(4'-cyano-3'-iodophenyl)-3-bromo-2-hydroxy-2-methylpropanamide 
• 793668-26-5 4-(4,4-dimethyl-2,5-dioxo-imidazolidin-1-yl)-2-iodo-benzonitrile 
• 793668-27-6 2-iodo-4-(3,4,4-trimethyl-2,5-dioxo-imidazolidin-1-yl)-benzonitrile 
• 793668-25-4 4-(5-imino-4,4-dimethyl-2-oxo-imidazolidin-1-yl)-2-iodo-benzonitrile 
• 793668-33-4 4-[3-(4-hydroxy-butyl)-4,4-dimethyl-2,5-dioxo-imidazolidin-1-yl]-2-iodo-benzonitrile 
• 793668-32-3 4-{3-[4-(tert-butyl-dimethyl-silanyloxy)-butyl]-4,4-dimethyl-2,5-dioxo-imidazolidin-1-yl}-2-iodo-benzonitrile 
• 300627-68-3 DTIB 
• 300627-64-9 4-[4,4-dimethyl-3-(4-hydroxybutyl)-5-imino-2-thioxo-1-imidazoldinyl]-2-iodobenzonitrile 
• 573760-03-9 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-2-iodobenzonitrile 
• 90356-78-8 N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfanyl]-2-hydroxy-2-methylpropanamide 

Relevant articles and documents

Chemical degradation of androgen receptor (Ar) using bicalutamide analog–thalidomide protacs

A series of PROTACs (PROteolysis-TArgeting Chimeras) consisting of bicalutamide analogs and thalidomides were designed, synthesized, and biologically evaluated as novel androgen receptor (AR) degraders. In particular, we found that PROTAC compound 13b could successfully demonstrate a targeted degradation of AR in AR-positive cancer cells and might be a useful chemical probe for the investigation of AR-dependent cancer cells, as well as a potential therapeutic candidate for prostate cancers.

METHOD FOR THE PREPARATION OF FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF

Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.